We use cookies to enhance your experience. By continuing to browse this site you agree to our use of cookies. More info.
Addressing the highest demands in imaging and analytics from any sample
ZEISS introduces its new field emission scanning electron microscope (FE-SEM) ZEISS GeminiSEM 450. The instrument combines ultrahigh resolution imaging with the capability to perform advanced analytics while maintaining flexibility and ease-of-use.
With ZEISS GeminiSEM 450, users benefit from high resolution, surface sensitive imaging and an optical system that ideally supports them in obtaining the best analytical results – especially when working with low voltages. High-throughput electron backscatter diffraction (EBSD) analysis and low voltage X-ray spectroscopy (EDS) deliver excellent results due to ZEISS Gemini 450’s ability to precisely and independently control spot size and beam current. With the Gemini 2 design, it is possible to always work under optimized conditions as the user can switch seamlessly between imaging and analytical modes at the touch of a button. This makes ZEISS GeminiSEM 450 the ideal platform for the highest demands in imaging and analytical performance.
In addition, ZEISS GeminiSEM 450 has been designed to cater for a broad variety of sample types from classical conductive metals to beam sensitive polymers. In particular the variable pressure technology of ZEISS GeminiSEM 450 reduces charging on non-conductive samples without compromising Inlens detection capabilities and at the same time enables high resolution EDS analysis by minimizing the skirt effect. Based on this design, ZEISS GeminiSEM 450 provides a flexible instrument suited to a broad variety of applications in materials science, industrial labs and life sciences.
“With ZEISS GeminiSEM 450 we have introduced a new FE-SEM flagship for highest performance analytics and ultrahigh resolution. In addition to this product launch, we are also rolling out significant enhancements to both the ZEISS GeminiSEM and ZEISS Sigma families. As an example, the ZEISS Sigma family now benefits from the introduction of the high resolution gun mode that has previously only been available on the ZEISS Gemini series” says Dr. Michael Albiez, head of electron microscopy at ZEISS.
Source: https://www.zeiss.com/
Tags: Diffraction, Electron, Electron Microscopy, High Throughput, Imaging, Microscope, Microscopy, Polymers, Spectroscopy, X-Ray
Please use one of the following formats to cite this article in your essay, paper or report:
Carl Zeiss Microscopy GmbH. (2018, August 22). ZEISS launches new field emission scanning electron microscope ZEISS GeminiSEM 450. News-Medical. Retrieved on August 08, 2022 from https://www.news-medical.net/news/20180822/ZEISS-launches-new-field-emission-scanning-electron-microscope-ZEISS-GeminiSEM-450.aspx.
Carl Zeiss Microscopy GmbH. "ZEISS launches new field emission scanning electron microscope ZEISS GeminiSEM 450". News-Medical. 08 August 2022. <https://www.news-medical.net/news/20180822/ZEISS-launches-new-field-emission-scanning-electron-microscope-ZEISS-GeminiSEM-450.aspx>.
Carl Zeiss Microscopy GmbH. "ZEISS launches new field emission scanning electron microscope ZEISS GeminiSEM 450". News-Medical. https://www.news-medical.net/news/20180822/ZEISS-launches-new-field-emission-scanning-electron-microscope-ZEISS-GeminiSEM-450.aspx. (accessed August 08, 2022).
Carl Zeiss Microscopy GmbH. 2018. ZEISS launches new field emission scanning electron microscope ZEISS GeminiSEM 450. News-Medical, viewed 08 August 2022, https://www.news-medical.net/news/20180822/ZEISS-launches-new-field-emission-scanning-electron-microscope-ZEISS-GeminiSEM-450.aspx.
In this interview, we speak to Charles Wells from Gates MRI about their current research into tuberculosis (TB) as well as the recent updated guidelines for TB care.
In this interview, we speak to Dr. Jordan Green about his latest research partnership with Modality.AI that investigated whether an app could be used to effectively diagnose speech decline due to ALS.
In this interview, we speak to Tom Kostrzewski, VP of Science and Technology at CN Bio, about their organ-on-a-chip product and the future of drug discovery.
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.
This site complies with the HONcode standard for trustworthy health information: verify here.
News-Medical.net - An AZoNetwork Site
Owned and operated by AZoNetwork, © 2000-2022